Impavido 50mg Capsule

Impavido 50mg Capsule Description:

Miltefosine belongs to class of drugs called antimicrobial agent. It interacts with essential proteins and chemicals which are required for growth and survival of parasite, thereby causing death.

Uses:

Impavido 50mg Capsule is used in the treatment of kala-azar.

Side Effects:

Headache, Nausea, Itching, Sleepiness, Decreased appetite, Abdominal pain, Diarrhoea, Vomiting, Dizziness, Increased transaminase level in blood, Increased creatinine level in blood.

Dosage:

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Impavido 50mg Capsule is to be taken with food.

FAQs

What is Impavido used for and how does it work?
Impavido is used to treat infection caused by parasites of the species Leishmania. It interacts with essential proteins and chemicals which are required for growth and survival of parasite, thereby causing death.

Buy Impavido 50mg Capsule Online From India At Best Price

If you are looking to buy Miltefosine (50mg) (7 capsules in 1 strip) online at affordable prices, then Drugssquare.com is your one-stop solution. Drugssquare is a leading supplier, exporter and retailer of generic & branded prescription drugs in the U.S. and all around the world. From Cancer to Hepatitis, and from AIDS to Kidney Disease, the company delivers medicines for all kinds of complex diseases, with savings of up to 70% or more.

Order Online to Get Impavido 50mg Capsule in –

South East Asia – China, Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Hong Kong, Japan, South Korea.

United Arab Emirates (UAE) – Iran, Saudi Arabia, Jordan.

North America – Venezuela, USA (United States of America), Suriname.

South America – Argentina, Chile, Colombia, Peru, Venezuela.

Europe – Romania, Georgia, Turkey, UK (United Kingdom), Ukraine, Latvia.

Russia CIS – Moldova, Uzbekistan, Kyrgyzstan.

African Countries – Nigeria, Kenya, Morocco, Libya, Zimbabwe.

Other Countries – Malaysia, Egypt, Australia, Italy and New Zealand.